有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(2,5-Difluorophenyl)methylsulfanyl]-3-piperidin-1-ylpyrazine | —— | C16H17F2N3S |
|
—— | 2-(3-Piperidin-1-ylpyrazin-2-yl)sulfanylacetonitrile | —— | C11H14N4S |
|
—— | 2-[3-(3,5-Dimethylpyrazol-1-yl)pyrazin-2-yl]sulfanylacetonitrile | —— | C11H11N5S |
|
—— | 2-[(4-Methylphenyl)methylsulfanyl]-3-pyrazol-1-ylpyrazine | —— | C15H14N4S |
|
—— | 2-[(2,5-Difluorophenyl)methylsulfanyl]-3-(3,5-dimethylpyrazol-1-yl)pyrazine | —— | C16H14F2N4S |
|
—— | N-[(5-chlorothiophen-2-yl)methyl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-prop-2-enylacetamide | —— | C16H14ClN3O3S2 |
|
—— | N-benzyl-N-ethyl-2-(3-pyrazol-1-ylpyrazin-2-yl)sulfanylacetamide | —— | C18H19N5OS |
|
—— | N-[(4-fluorophenyl)methyl]-2-(3-piperidin-1-ylpyrazin-2-yl)sulfanylacetamide | —— | C18H21FN4OS |
|
—— | N-[(4-fluorophenyl)methyl]-2-(3-pyrazol-1-ylpyrazin-2-yl)sulfanylacetamide | —— | C16H14FN5OS |
|
—— | 2-Benzylsulfanyl-3-piperidin-1-ylpyrazine | —— | C16H19N3S |
|
—— | 2-(3,5-Dimethylpyrazol-1-yl)-3-[(3-fluorophenyl)methylsulfanyl]pyrazine | —— | C16H15FN4S |
|
—— | N-[(2-fluorophenyl)methyl]-3-[(3-fluorophenyl)methylsulfanyl]pyrazin-2-amine | —— | C18H15F2N3S |
|
—— | N-[(4-methylphenyl)methyl]-2-(3-pyrazol-1-ylpyrazin-2-yl)sulfanylacetamide | —— | C17H17N5OS |
|
—— | 2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-[(4-fluorophenyl)methyl]acetamide | —— | C20H25FN4OS |
|
—— | 2-[(3,4-difluorophenyl)methylsulfanyl]-4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H21F2N3S |
|
—— | 3-[(3,4-difluorophenyl)methylsulfanyl]-N-[(2-fluorophenyl)methyl]pyrazin-2-amine | —— | C18H14F3N3S |
|
—— | N-[(4-fluorophenyl)methyl]-2-[3-[(2-fluorophenyl)methylamino]pyrazin-2-yl]sulfanylacetamide | —— | C20H18F2N4OS |
|
—— | N-cyclohexyl-2-[3-[(2-fluorophenyl)methylamino]pyrazin-2-yl]sulfanylacetamide | —— | C19H23FN4OS |
|
—— | 2-(3-Pyrazol-1-ylpyrazin-2-yl)sulfanylacetonitrile | —— | C9H7N5S |
|
—— | N-butyl-2-[3-[(2-fluorophenyl)methylamino]pyrazin-2-yl]sulfanylacetamide | —— | C17H21FN4OS |
|
—— | 2-(3,5-Dimethylpyrazol-1-yl)-3-[(4-methylphenyl)methylsulfanyl]pyrazine | —— | C17H18N4S |
|
—— | 2-[(3-Fluorophenyl)methylsulfanyl]-3-pyrazol-1-ylpyrazine | —— | C14H11FN4S |
|
—— | 4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]-2-[(3-fluorophenyl)methylsulfanyl]pyrimidine | —— | C18H22FN3S |
|
—— | N-butyl-2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetamide | —— | C17H28N4OS |
|
—— | 4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]-2-[(4-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]-2-[(4-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | N-[(2-fluorophenyl)methyl]-3-[(4-methylphenyl)methylsulfanyl]pyrazin-2-amine | —— | C19H18FN3S |
|
—— | 2-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetonitrile | —— | C13H18N4S |
|
—— | 2-benzylsulfanyl-4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H23N3S |
|
—— | 2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetonitrile | —— | C13H18N4S |
|
—— | 2-[(2,5-difluorophenyl)methylsulfanyl]-4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H21F2N3S |
|
—— | methyl 2-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetate | —— | C14H21N3O2S |
|
—— | 2-benzylsulfanyl-4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H23N3S |
|
—— | 3-benzylsulfanyl-N-[(2-fluorophenyl)methyl]pyrazin-2-amine | —— | C18H16FN3S |
|
—— | 4-[(3,4-Difluorophenyl)methylsulfanyl]-6-(3,5-dimethylpyrazol-1-yl)pyrimidine | —— | C16H14F2N4S |
|
—— | N-benzyl-2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-ethylacetamide | —— | C22H30N4OS |
|
—— | methyl 2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetate | —— | C14H21N3O2S |
|
—— | 4-[(3S,5R)-3,5-dimethylpiperidin-1-yl]-2-[(3-fluorophenyl)methylsulfanyl]pyrimidine | —— | C18H22FN3S |
|
—— | 2-[4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C21H28N4OS |
|
—— | 2-[(2,5-difluorophenyl)methylsulfanyl]-4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H21F2N3S |
|
—— | 4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]-2-[(3-fluorophenyl)methylsulfanyl]pyrimidine | —— | C18H22FN3S |
|
—— | 2-[(3,4-difluorophenyl)methylsulfanyl]-4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H21F2N3S |
|
—— | N-benzyl-2-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-ethylacetamide | —— | C22H30N4OS |
|
—— | N-butyl-2-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetamide | —— | C17H28N4OS |
|
—— | methyl 2-[4-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanylacetate | —— | C14H21N3O2S |
|
—— | 2-[4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-[(4-methylphenyl)methyl]acetamide | —— | C21H28N4OS |
|
—— | 4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-2-[(4-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 2-[(2,5-difluorophenyl)methylsulfanyl]-4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]pyrimidine | —— | C18H21F2N3S |
|
—— | N-butyl-2-[6-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-yl]sulfanylacetamide | —— | C15H21N5OS |
|
—— | 2-[4-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyrimidin-2-yl]sulfanyl-N-[(4-fluorophenyl)methyl]acetamide | —— | C20H25FN4OS |
|